Ronen Tchelet
Known title: VP of Research and Bus. DvlpmtCIK: 0001761230
Associated companies
Transaction History
| DYAI | ▲ Buy | Grant | 18,064 | $0 | 1/2/2026 | View on chart |
| DYAI | ▲ Buy | Grant | 8,980 | $0 | 1/2/2025 | View on chart |
| DYAI | ▲ Buy | Grant | 11,169 | $0 | 3/13/2024 | View on chart |
| DYAI | ▲ Buy | Grant | 12,684 | $18K | 1/3/2023 | View on chart |
| DYAI | ▲ Buy | Option Exercise | 1,089 | $2K | 7/8/2022 | View on chart |
| DYAI | ▼ Sell | Open Market | 1,089 | $4K | 7/8/2022 | View on chart |
| DYAI | ▲ Buy | Option Exercise | 7,854 | $12K | 7/7/2022 | View on chart |
| DYAI | ▼ Sell | Open Market | 7,854 | $27K | 7/7/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
Dyadic International Included in After-Market Movers List
Dyadic International was featured in a Benzinga report highlighting health care stocks that moved during Monday's after-market session. The stock currently trades well below its analyst average target price, with a 52-week range spanning from $0.34 to $1.60. This inclusion reflects recent trading activity rather than a specific company announcement.
Dyadic International Included in After-Market Movers List. Dyadic International was featured in a Benzinga report highlighting health care stocks that moved during Monday's after-market session. The stock currently trades well below its analyst average target price, with a 52-week range spanning from $0.34 to $1.60. This inclusion reflects recent trading activity rather than a specific company announcement.